PLG and diabetic kidney disease: Additionally, plasma ADAMTS-13 levels are decreased in diabetic nephropathy, potentially due to peripheral consumption for the cleavage of chronically increased VWF and an increase in circulating proteolytic enzymes (thrombin and plasmin) that cleave ADAMTS-13.